"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
A study looking for biomarkers of ovarian cancer
In this study researchers are looking at the blood and tissue samples of women who are having their ovaries removed by surgery. It is open to women who have ovarian cancer and non cancerous (
More about this trial
Researchers will look for substances (
The main aim is to identify biomarkers that might help doctors diagnose ovarian cancer earlier.
Who can enter
The following bullet points list the entry conditions for this study. Talk to your doctor or the study team if you are unsure about any of these. They will be able to advise you.
You may be able to join this study if you are at least 18 years old and are in one of the following situations. You
- are having surgery to remove your ovaries
- are having a sample of tissue (
biopsy) taken from your ovaries or omentumbecause you might have cancer
Lynch syndromeand are having both your ovaries removed to reduce the risk of having cancer
- are having your womb removed (
hysterectomy)or your ovaries removed ( oophorectomy)because you have a non cancerous (benign) condition such as menorrhagia or fibroids and you have had an ultrasound scanthat shows your ovaries are normal
You cannot join this study if any of these apply. You
- have an infection
- are unable to understand English well enough or English isn’t your first language
The researchers need 224 people with ovarian cancer and 224 people who have a benign (non cancerous) condition to join.
The researcher will
- ask you a few questions about your health
- take a blood sample
- ask for a sample of your ovary tissue removed when you have surgery
The team use the samples to look for substances (biomarkers). These biomarkers might help doctors diagnose ovarian cancer earlier. And also tell them if treatment is working.
There are no extra hospital visits.
How to join a clinical trial
Dr Lavinia Margarit
Abertawe Bro Morgannwg University Health Board
NIHR Clinical Research Network: Cancer
St David's Medical Foundation